申请人:Eli Lilly and Company
公开号:US06358972B1
公开(公告)日:2002-03-19
The present invention relates to a compound of formula (I): or a pharmaceutical acid addition salt thereof; which is useful for activating 5-HT1f receptors and inhibiting protein extravasation in a mammal.
本发明涉及以下化合物(I)的化合物或其药用酸盐;该化合物对于激活哺乳动物体内的5-HT1f受体和抑制蛋白外渗具有用处。